KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Medpace Holdings (MEDP) Accumulated Depreciation & Amortization (2016 - 2025)

Medpace Holdings has reported Accumulated Depreciation & Amortization over the past 11 years, most recently at $123.3 million for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 24.68% to $123.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $123.3 million through Dec 2025, up 24.68% year-over-year, with the annual reading at $123.3 million for FY2025, 24.68% up from the prior year.
  • Accumulated Depreciation & Amortization was $123.3 million for Q4 2025 at Medpace Holdings, up from $98.9 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $123.3 million in Q4 2025 and troughed at $51.1 million in Q4 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $79.4 million (2023), against an average of $83.0 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 30.67% in 2021 and later rose 21.56% in 2022.
  • Tracing MEDP's Accumulated Depreciation & Amortization over 5 years: stood at $51.1 million in 2021, then rose by 21.56% to $62.1 million in 2022, then rose by 27.83% to $79.4 million in 2023, then increased by 24.51% to $98.9 million in 2024, then grew by 24.68% to $123.3 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $123.3 million, $98.9 million, and $79.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.